Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 4, 2005

View Archived Issues

Combined irinotecan and trabectedin therapy effective in preclinical models of rhabdomyosarcoma

Vanadocene dithiocarbamate inhibits fertility in rabbit and pig models

mGlu2/3 receptor antagonist suppresses growth of glioma xenografts in mice

Quetiapine reduces agitation in patients with dementia

Adhibit prevents formation of surgical adhesions after myomectomy

Once-weekly PCK-3145 induces antitumor effects in prostate cancer patients

Preclinical data on Ostabolin-C

Novel VLA-4 antagonist prevents pulmonary inflammation and airway hyperreactivity in vivo

HU-331 inhibits Topo II and produces antiangiogenic effects in vitro and in vivo

New data on the safety and immunogenicity of StaphVAX vaccine in orthopedic patients

Boswellia serrata extract reduces diarrhea frequency in patients with collagenous colitis

Update on the antitumor effects of temozolomide in metastatic melanoma

Promising results reported for Nastech's intranasal PTH (1-34) formulation

GlaxoSmithKline: Q2 2005

New phase III data confirm the efficacy of RSD-1235 in the treatment of arrhythmia

Pharming to study rhC1INH for new indications

CNTO-1275 shows promise in moderate to severe psoriasis

AVI introduces ESPRIT with utility in Duchenne muscular dystrophy

Aspreva and Roche conclude SPA for CellCept in lupus nephritis

Guilford stockholders approve MGI Pharma merger

Update on rasagiline in Parkinson's disease

New mechanism of action discovered for Aspirin

ConjuChem updates DAC:GLP-1 and PC-DAC:Exendin-4 programs

Alcon patent claims 5-HT2 receptor agonists for use in glaucoma

Novel psychopharmacological agents disclosed in recent patents

Wyeth launches Mylotarg in Japan for acute myelocytic leukemia

Clinical hold maintained on erectile dysfunction study of alagebrium

BioAlliance commences European approval process for miconazole Lauriad

FDA extends action date for Revlimid NDA

Novel agents for dermatological disorders emerge from pharma R&D

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.